In the wake of recent attacks by US short-seller Muddy Waters, Eurofins issued further clarifications on Thursday, designed to reassure shareholders, creditors, employees and customers alike.

In a press release, the bio-analysis giant focuses in particular on the links between the company and Analytical Bioventures SCA (ABSCA), a holding company owned by its CEO, Dr. Gilles Martin.

On this point, the group assures that it is currently gathering a certain amount of information on the subject, with the aim of presenting it to the market shortly.

The Group stresses, however, that its idea is to eventually allow the company to buy back the facilities currently leased to ABSCA, subject to the approval of shareholders not concerned (other than ABSCA and its representatives).

With regard to governance issues, Eurofins also says it is considering the possible appointment of at least one new independent director to its Board.

In the meantime, the company says it no longer intends to respond to the accusations made by Muddy Water, so that it can concentrate its resources on its strategic, operational and financial performance.

The company says it intends to return to its fundamentals when it publishes its first-half results, scheduled for July 24.

On the Paris Bourse, Eurofins Scientific shares were up by around 0.8% on Thursday morning following these announcements.

Copyright (c) 2024 CercleFinance.com. All rights reserved.